- Home
- CLDI vs CMBM Comparison
CLDI vs CMBM Comparison
Compare CLDI & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- CMBM
- Stock Information
- Founded
- CLDI 2014
- CMBM 2011
- Country
- CLDI United States
- CMBM United States
- Employees
- CLDI N/A
- CMBM N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- CLDI Health Care
- CMBM Technology
- Exchange
- CLDI Nasdaq
- CMBM Nasdaq
- Market Cap
- CLDI 20.2M
- CMBM 18.6M
- IPO Year
- CLDI N/A
- CMBM 2019
- Fundamental
- Price
- CLDI $1.60
- CMBM $0.72
- Analyst Decision
- CLDI
- CMBM Buy
- Analyst Count
- CLDI 0
- CMBM 1
- Target Price
- CLDI N/A
- CMBM $3.00
- AVG Volume (30 Days)
- CLDI 484.3K
- CMBM 173.4K
- Earning Date
- CLDI 11-11-2025
- CMBM 11-06-2025
- Dividend Yield
- CLDI N/A
- CMBM N/A
- EPS Growth
- CLDI N/A
- CMBM N/A
- EPS
- CLDI N/A
- CMBM N/A
- Revenue
- CLDI N/A
- CMBM $172,215,000.00
- Revenue This Year
- CLDI N/A
- CMBM N/A
- Revenue Next Year
- CLDI N/A
- CMBM $17.73
- P/E Ratio
- CLDI N/A
- CMBM N/A
- Revenue Growth
- CLDI N/A
- CMBM N/A
- 52 Week Low
- CLDI $1.51
- CMBM $0.23
- 52 Week High
- CLDI $46.68
- CMBM $2.08
- Technical
- Relative Strength Index (RSI)
- CLDI 30.60
- CMBM 49.46
- Support Level
- CLDI $1.51
- CMBM $0.62
- Resistance Level
- CLDI $1.68
- CMBM $0.77
- Average True Range (ATR)
- CLDI 0.10
- CMBM 0.06
- MACD
- CLDI 0.14
- CMBM 0.00
- Stochastic Oscillator
- CLDI 22.97
- CMBM 44.10
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.